Tumor Ablation Market on Track to Reach USD 4.17 billion by 2032- Propelled by a 11.3% CAGR | Key Players- AngioDynamics Inc, Boston Scientific Corp, BVM Medical Ltd

𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

• The global tumor ablation market size was valued at USD 1.60 billion in 2023.
• The market is expected to expand at a CAGR of 11.3% from 2024 to 2032.
• The industry is expected to grow to USD 4.17 billion by 2032.

𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Tumor ablation devices are contemporary healthcare tools and techniques used for treating tumors, particularly in cases where surgery is not possible or when patients opt for less invasive choices. These devices work by removing cancerous or non-cancerous growths through the application of localized heat or freezing methods. RFA and MWA devices utilize high-frequency electromagnetic waves to generate heat, successfully cooking and destroying tumor cells. In contrast, cryoablation devices use extremely cold temperatures to freeze and remove the tumor.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐰𝐢𝐭𝐡 𝐀𝐧 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐋𝐨𝐨𝐤 𝐚𝐭 𝐭𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬:

The increasing number of individuals with cancer has increased the demand for procedures to remove tumors. Radiofrequency, microwave, cryoablation, and laser ablation are methods that provide accurate removal of cancer cells while protecting healthy tissue. Moreover, the increasing preference for minimally invasive methods by patients and surgeons will contribute to the growth of the tumor ablation market.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬:

In this extremely competitive industry, major rivals constantly innovate and differentiate their products in an effort to take the lead in the market. Some of the major players participating in the tumor ablation industry are:
• AngioDynamics Inc.
• Boston Scientific Corp.
• BVM Medical Ltd.
• BTG International Ltd.
• EDAP TMS S.A.
• Integra LifeSciences Holdings Corp.
• Medtronic plc.
• Mermaid Medical
• SonaCare Medical LLC
• St. Jude Medical Inc.

𝐍𝐞𝐞𝐝 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐞𝐟𝐨𝐫𝐞 𝐩𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market/inquire-before-buying

𝐂𝐨𝐮𝐧𝐭𝐫𝐲-𝐖𝐢𝐬𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

The tumor ablation market is mainly segmented on the basis of technology, mode of treatment, application, and region. Based on the technology analysis, the radiofrequency ablation segment held the largest revenue share in 2023 due to its ability to efficiently and accurately remove solid tumors in the liver and kidney.
Furthermore, according to the application analysis, during the projection period, lung cancer was recognized as the market segment with the fastest growth. Smoking is the primary cause of lung cancer, responsible for the majority of cases.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market

𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• In 2022, the radiofrequency ablation segment accounted for the largest revenue share in the tumor ablation market. The precision and safety of radiofrequency ablation, which have significantly improved with recent technological advancements, make it a significant choice for both physicians and patients.

• The lung cancer segment growing at the fastest as smoking is the leading cause of lung cancer, accounting for the majority of cases.

• In 2022, North America accounted for the largest market share in the tumor ablation market. Several key elements, such as governmental support for robust healthcare, high purchasing power, accessible reimbursements, and rising incidences of cancer, fuel the growth of this region. In the US, the Patient Protection and Affordable Care Act (PPACA) acts as a standard, advocating for the enhancement of healthcare quality and affordability through comprehensive health coverage policies. This, in turn, reduces healthcare costs for individuals and the government.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐏𝐌𝐑'𝐬 𝐓𝐮𝐦𝐨𝐫 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐟𝐫𝐨𝐦 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

https://www.globenewswire.com/news-release/2024/08/23/2934895/0/en/Tumor-Ablation-Market-Set-to-Expand-at-a-Staggering-11-3-CAGR-Reaching-USD-4-17-Billion-by-2032-Polaris-Market-Research.html

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Non-Pvc Iv Bags Market: https://www.polarismarketresearch.com/industry-analysis/non-pvc-iv-bags-market

Endometrial Ablation Market: https://www.polarismarketresearch.com/industry-analysis/endometrial-ablation-market

Bioimpedance Analyzers Market: https://www.polarismarketresearch.com/industry-analysis/bioimpedance-analyzer-market

Oxygen Scavengers Market: https://www.polarismarketresearch.com/industry-analysis/oxygen-scavenger-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.